FDA commissioner Lester Crawford called the Pharmaceutical Research and Manufacturers of America’s (PhRMA) voluntary limits on DTC advertising a “step in the right direction,” but that said the guidelines released last week, will need to be monitored.
“We don’t need (advertisements) to be flippant or frivolous or obscene, and I think the new guidelines that PhRMA has put forward have the possibility of causing improvement,” Crawford told Reuters on the sidelines of an industry conference in Boston.
“It will probably add more work for the FDA,” Crawford said. “We will watch them carefully and reserve judgment, but I think it’s a step in the right direction.”
Crawford welcomes PhRMA DTC guidelines
FDA commissioner Lester Crawford called the Pharmaceutical Research and Manufacturers of America’s (PhRMA) voluntary limits on DTC advertising a “step in the right direction,” but that said the guidelines released last week, will need to be monitored.
